A Novel MUC16 (CA125) Monoclonal Antibody

被引：0
|
作者：
da Silva, L. Marcos [1 ]
Campos, D. [1 ]
Mandel, U. [2 ]
Bennett, E. P. [2 ]
Blixt, O. [2 ]
Levery, S. B. [2 ]
David, L. [1 ]
Clausen, H. [2 ]
机构：
[1] Univ Porto, IPATIMUP Inst Mol Pathol & Immunol, Oporto, Portugal
[2] Univ Copenhagen, Copenhagen Ctr Glyc, ICMM, Copenhagen, Denmark
来源：
EUROPEAN JOURNAL OF CANCER | 2012年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
173
引用
收藏
页码：S42 / S42
页数：1
相关论文
共 50 条
  • [31] Synthesis and structural characterization of the peptide epitope of the ovarian cancer biomarker CA125 (MUC16)
    Berman, Zach T.
    Moore, Lee J.
    Knudson, Kathleen E.
    Whelan, Rebecca J.
    TUMOR BIOLOGY, 2010, 31 (05) : 495 - 502
  • [32] Efficient CAR T cell targeting of the CA125 extracellular repeat domain of MUC16
    Casey, Nicholas P.
    Kleinmanns, Katrin
    Forcados, Christopher
    Gelebart, Pascal F.
    Joaquina, Sandy
    Lode, Martine
    Benard, Emmanuelle
    Kaveh, Fatemeh
    Caulier, Benjamin
    Gjerde, Christiane Helgestad
    de Jalon, Elvira Garcia
    Warren, David J.
    Lindemann, Kristina
    Rokkones, Erik
    Davidson, Ben
    Myhre, Marit Renee
    Kvalheim, Gunnar
    Bjorge, Line
    McCormack, Emmet
    Inderberg, Else Marit
    Walchli, Sebastien
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (04)
  • [33] The role of the ovarian tumor marker CA125 (MUC16) in the suppression of human immune responses
    Belisle, JA
    Arens, JA
    Migneault, M
    Rancourt, C
    Felder, M
    Connor, J
    Patankar, MS
    JOURNAL OF IMMUNOTHERAPY, 2005, 28 (06) : 635 - 636
  • [34] MUC16/CA125, TNFα and IFNγ are co-expressed in malignant gynecologic neoplasms
    Morgado, Micaela
    Sutton, Margie N.
    Simmons, Mary
    Liu, Jinsong
    Lu, Zhen
    Papadopoulos, Pamela E.
    Bast, Robert C.
    Carson, Daniel D.
    CANCER RESEARCH, 2015, 75
  • [35] Molecular cloning of the CA125 ovarian cancer antigen - Identification as a new mucin, MUC16
    Yin, BWT
    Lloyd, KO
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (29) : 27371 - 27375
  • [36] MUC16 (CA125) regulates epithelial ovarian cancer cell growth, tumorigenesis and metastasis
    Theriault, Catherine
    Pinard, Maxime
    Comamala, Marina
    Migneault, Martine
    Beaudin, Julie
    Matte, Isabelle
    Boivin, Marianne
    Piche, Alain
    Rancourt, Claudine
    GYNECOLOGIC ONCOLOGY, 2011, 121 (03) : 434 - 443
  • [37] CA125 (MUC16) gene silencing suppresses growth properties of ovarian and breast cancer cells
    Reinartz, Silke
    Failer, Sophie
    Schuell, Tina
    Wagner, Uwe
    EUROPEAN JOURNAL OF CANCER, 2012, 48 (10) : 1558 - 1569
  • [38] Pre-clinical comparison of approaches to increasing the immunogenicity of CA125 (MUC16) DNA vaccines
    Ragupathi, Govind
    Koide, Fusataka
    Yin, Beatrice Wt
    Lloyd, Kenneth O.
    Hannaman, Drew
    Livingston, Philip O.
    CANCER RESEARCH, 2006, 66 (08)
  • [39] Integrated genomic analysis identifies PLEC1 as a molecular target of MUC16/CA125
    Blum, A.
    Tanner, E.
    Bisogna, M.
    Dao, F.
    Thapi, D.
    Spriggs, D.
    Levine, D.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S162 - S162
  • [40] Regulation of MUC16 (CA125) release in ovarian cancer cells by cytokines and growth factors.
    Spriggs, E
    Spriggs, C
    Thapi, D
    Awtry, C
    Spriggs, DR
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9139S - 9140S
12345